Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Complement Abnormality”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Not applicableUnknownNCT05258643
What this trial is testing

The Role of Natural Killer, Complement and T-lymphocytes in COVID-19 Disease, a Prospective Monocentric Study

Who this might be right for
Complement AbnormalityPeripheral Blood Mononuclear CellsCovid19
Universitair Ziekenhuis Brussel 150
Early research (Phase 1)Study completedNCT04103489
What this trial is testing

The Use of Eculizumab in HELLP Syndrome

Who this might be right for
HELLP Syndrome (HELLP), Third TrimesterComplement AbnormalityMorbidity;Newborn+2 more
Johns Hopkins University 3
Testing effectiveness (Phase 2)Looking for participantsNCT04183101
What this trial is testing

Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy

Who this might be right for
C3 GlomerulopathyMembranoproliferative GlomerulonephritisComplement Abnormality+2 more
Region Skane 30
Testing effectiveness (Phase 2)Ended earlyNCT04725812
What this trial is testing

Complement Regulation to Undo Systemic Harm in Preeclampsia

Who this might be right for
PreeclampsiaSevere PreeclampsiaEculizumab+9 more
Cedars-Sinai Medical Center 2